characteristics.text: SAMN32373529
characteristics.characteristic: External Id
characteristics.text: Efrat Shema, Department of Immunology & Regenerative Biology, Weizmann Institute of Science
characteristics.characteristic: INSDC center name
characteristics.text: 2024-06-25T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-06-25T00:15:11.909Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16259576
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16259576
characteristics.characteristic: SRA accession
characteristics.text: SU-DIPG13
characteristics.characteristic: cell line
characteristics.text: Glioma
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: H3.3K27M
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: MARS-seq on SU-DIPG13 treated with Vorinostat for 72h+Sulfopin for 8d
characteristics.characteristic: source_name
characteristics.text: 8 days/72 hours
characteristics.characteristic: time
characteristics.text: SulfoVorino3
characteristics.characteristic: title
characteristics.text: Sulfopin+Vorinostat
characteristics.characteristic: treatment